rs2072243

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000725301.1(ENSG00000294706):​n.43G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.204 in 166,954 control chromosomes in the GnomAD database, including 3,757 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.20 ( 3377 hom., cov: 33)
Exomes 𝑓: 0.21 ( 380 hom. )

Consequence

ENSG00000294706
ENST00000725301.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.539

Publications

4 publications found
Variant links:
Genes affected
HS3ST3B1 (HGNC:5198): (heparan sulfate-glucosamine 3-sulfotransferase 3B1) The protein encoded by this gene is a type II integral membrane protein that belongs to the 3-O-sulfotransferases family. These proteins catalyze the addition of sulfate groups at the 3-OH position of glucosamine in heparan sulfate. The substrate specificity of individual members of the family is based on prior modification of the heparan sulfate chain, thus allowing different members of the family to generate binding sites for different proteins on the same heparan sulfate chain. Following treatment with a histone deacetylase inhibitor, expression of this gene is activated in a pancreatic cell line. The increased expression results in promotion of the epithelial-mesenchymal transition. In addition, the modification catalyzed by this protein allows herpes simplex virus membrane fusion and penetration. A very closely related homolog with an almost identical sulfotransferase domain maps less than 1 Mb away. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.292 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HS3ST3B1NM_006041.3 linkc.-456C>T upstream_gene_variant ENST00000360954.3 NP_006032.1 Q9Y662
HS3ST3B1NR_130138.2 linkn.-18C>T upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000294706ENST00000725301.1 linkn.43G>A non_coding_transcript_exon_variant Exon 1 of 1
HS3ST3B1ENST00000360954.3 linkc.-456C>T upstream_gene_variant 1 NM_006041.3 ENSP00000354213.2 Q9Y662
HS3ST3B1ENST00000466596.5 linkn.-456C>T upstream_gene_variant 2 ENSP00000436078.1 Q9Y662

Frequencies

GnomAD3 genomes
AF:
0.203
AC:
30907
AN:
152132
Hom.:
3373
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.138
Gnomad AMI
AF:
0.358
Gnomad AMR
AF:
0.217
Gnomad ASJ
AF:
0.304
Gnomad EAS
AF:
0.235
Gnomad SAS
AF:
0.305
Gnomad FIN
AF:
0.131
Gnomad MID
AF:
0.380
Gnomad NFE
AF:
0.232
Gnomad OTH
AF:
0.237
GnomAD4 exome
AF:
0.213
AC:
3138
AN:
14704
Hom.:
380
Cov.:
0
AF XY:
0.220
AC XY:
1650
AN XY:
7504
show subpopulations
African (AFR)
AF:
0.148
AC:
87
AN:
588
American (AMR)
AF:
0.238
AC:
80
AN:
336
Ashkenazi Jewish (ASJ)
AF:
0.263
AC:
150
AN:
570
East Asian (EAS)
AF:
0.253
AC:
174
AN:
688
South Asian (SAS)
AF:
0.227
AC:
107
AN:
472
European-Finnish (FIN)
AF:
0.117
AC:
63
AN:
540
Middle Eastern (MID)
AF:
0.378
AC:
28
AN:
74
European-Non Finnish (NFE)
AF:
0.216
AC:
2249
AN:
10434
Other (OTH)
AF:
0.200
AC:
200
AN:
1002
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
114
227
341
454
568
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.203
AC:
30926
AN:
152250
Hom.:
3377
Cov.:
33
AF XY:
0.200
AC XY:
14905
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.138
AC:
5721
AN:
41566
American (AMR)
AF:
0.217
AC:
3321
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.304
AC:
1056
AN:
3470
East Asian (EAS)
AF:
0.236
AC:
1216
AN:
5160
South Asian (SAS)
AF:
0.305
AC:
1469
AN:
4824
European-Finnish (FIN)
AF:
0.131
AC:
1388
AN:
10616
Middle Eastern (MID)
AF:
0.367
AC:
108
AN:
294
European-Non Finnish (NFE)
AF:
0.232
AC:
15808
AN:
67996
Other (OTH)
AF:
0.243
AC:
513
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1266
2533
3799
5066
6332
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
340
680
1020
1360
1700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.205
Hom.:
415
Bravo
AF:
0.208
Asia WGS
AF:
0.258
AC:
898
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
3.5
DANN
Benign
0.93
PhyloP100
-0.54
PromoterAI
0.044
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2072243; hg19: chr17-14204380; COSMIC: COSV62906239; API